In the last two chapters, we talked about what ESR is and the applications of ESR, CRP and CBC analysis. ESR is an acute phase reactant and serves as a marker for inflammation. It correlates with disease activity and response to therapy. We understand that single tests are not adequate to confirm any diagnosis, but they do give us important clues.
Today, all these tests can be performed via an automated analyzer. You do not have to do this by yourself anymore. This helps to streamline the workflow of the laboratory and allows patients to get the diagnosis in the earliest time possible.
So, what are the advantages of automated measurement of ESR with CBC in one analysis from clinical laboratory perspectives?
Advantages from clinical laboratory perspectives
Reducing the volume of blood to draw from patients, especially for children and the elderly
Only one tube of blood is required for ESR and CBC tests, reducing the workload of blood drawing and labor and consumables cost
Simplified workflow
For manual method
- Additional tubes
- Additional manpower
- Time consuming
- Potential biosafety hazards due to the blood exposure during the whole process
For instrument method
- Additional instrument cost
- Additional maintenance cost
Shortening the turnaround time (TAT)
Avoiding manual input of incorrect results
CBC and other parameters as well as ESR results will be combined, and true negative samples will be automatically validated and then transmitted to the LIS. Lab technicians only need to verify the abnormal results.
Mindray has launched the new BC-700 Series, a revolutionary hematology analyzer series that incorporates both CBC and ESR tests. This series, including two open vial models BC-700/BC-720 and two autoloader models BC-760/BC-780, is designed to empower medium-volume laboratories with advanced diagnostics technologies that are applied in the premium products.
